Multiple Myeloma Treatment Regimens
Find detailed drug treatment regimens for multiple myeloma, including primary therapy for both transplant candidates and non-transplant candidates.
Multiple Myeloma
Uncertainty Common in Primary Family Caregivers of Patients With Multiple Myeloma
Researchers find trends among physical and emotional challenges associated with being the primary family caregiver of a patient with multiple myeloma.
Shorter Duration of Cryotherapy as Effective as Standard Therapy Prior to HSCT for Multiple Myeloma
This study sought to determine the noninferiority of 2 hours of cryotherapy vs standard 7 hours prior to high-dose melphalan before autologous HSCT.
Ixazomib Maintenance After ASCT Improves Progression-Free, Overall Survival in Multiple Myeloma
An international study sought to determine if ixazomib maintenance after autologous stem cell transplantation would improve progression-free survival and overall survival.
Continuous Therapy May Be Beneficial in Patients With Newly Diagnosed Multiple Myeloma
Continuous therapy appears to be the preferred treatment modality in newly diagnosed patients with multiple myeloma (MM).
Depth of Response Translates Into Real-World Benefit in Multiple Myeloma
Depth of response corresponded to overall survival and time to next treatment in real-world patients with relapsed/refractory multiple myeloma.
Study Determines Preferred Attributes of PI Combination Therapies for R/R Multiple Myeloma
In this study, researchers sought to determine the preferred treatment attributes of patients with RRMM, and which they are willing to let go in trade-offs.
Early Findings Indicate P-BCMA-101 May Be Effective, Tolerable in R/R Multiple Myeloma
Early results of phase 1, dose-escalation trial demonstrate efficacy and safety of P-BCMA-101 CAR-T cell therapy in patients with R/R MM.
Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value
Stringent CR criteria may not predict clinical outcomes for patients with multiple myeloma.
Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma
Researchers conducted a study to gauge the potential acceptance of sensored medication devices among patients with multiple myeloma.
Next post in Multiple Myeloma
